GlassScriptPhysician profile
Michael J Wells
NPI 1790787067
$1,797.83
in general payments reported to CMS, 2019-2025
17 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.78 · 2020: $367 · 2021: $617 · 2022: $252 · 2023: $125 · 2024: $77.64 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $584.67 | 2020-2021 | |
| Sientra, INC. | $308.84 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $209.08 | 2021-2025 | Dupixent, Libtayo |
| Motiva USA, LLC | $170.85 | 2025 | |
| Allergan, INC. | $152.46 | 2022 | |
| Sun Pharmaceutical Industries INC. | $95.15 | 2019-2024 | |
| Bioventus LLC | $83.80 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.93 | 2025 | |
| Lilly USA, LLC | $21.65 | 2025 | Taltz, Ebglyss |
| Genentech USA, INC. | $20.75 | 2022 | |
| Ucb, INC. | $20.17 | 2020 | |
| Organogenesis INC. | $19.84 | 2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $18.83 | 2021 | |
| Almirall LLC | $16.51 | 2019 | |
| Mimedx Group, INC. | $16.35 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.12 | 2022 | |
| Medline Industries LP | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.